Trials / Sponsors / BioNTech US Inc.
BioNTech US Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Ad Unresectable Melanoma, Metastatic Melanoma | Phase 1 | 2020-12-01 |
| Terminated | A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melan Metastatic Melanoma | Phase 1 | 2018-10-08 |
| Completed | A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer Carcinoma, Non-Small-Cell Lung, Lung Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung | Phase 1 | 2018-05-04 |
| Completed | A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer Urinary Bladder Cancer, Bladder Tumors, Transitional Cell Carcinoma of the Bladder | Phase 1 | 2016-10-01 |